4. Zimmer Biomet: Rosa
Zimmer Biomet (NYSE:ZBH) is also seeking to compete against Stryker in the robot-assisted knee surgery space through its Rosa platform. The Rosa system boasts 2D X-ray and 3D pre-operative planning tools, allowing surgeons to conduct virtual procedures ahead of the actual surgeries — as well as real-time intraoperative data on soft tissue and bone anatomy.
Zimmer Biomet acquired the initial Rosa technology through its roughly $132 million purchase of French robot-assisted surgery firm Medtech in 2016.
The company had nearly 300 Rosa knee systems placed around the world by the end of 2020.